Abstract
CURRENT PHARMA SCENARIO 2019

Pushplata Sherekar* and Namdeo Shinde

ABSTRACT

The Indian pharmaceutical industry has been growing at compounded annual growth rate(CAGR) of more than 15%over the last five years[3] Globally Indian Pharmaceutical sector Industry supplies over 50 %[1] global demand for various vaccine, 40%[1] of generic demand in the US and 25%- of all medicine in UK.India enjoys an important position in the global pharmaceutical sector. The country also has a large pool of scientists and engineers who have potential to steer the industry ahead to even higher level. Presently over 80%[4] of the antiretroviral drugs, used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian Pharmaceutical Firms. The world‟s largest industry iscurrent pharmaceutical industry,It is due to worldwide revenues of approximately US$2.8[1] trillions. The major changes has seen in Pharmaceutical industry in recent years, that placed now demand on payers, provides and manufactures customers now demand the same choice and convenience from pharmaceutical industry that they find the other segment. Indian Pharmaceutical Industry is poised for high consistent growth over the next few years. Current top Indian companies like Ranbaxy, DRL, CIPLA, and DABUR have already established their presence. The pharmaceutical industries are heavily dependent on research and development for new product and growth. However basic research (Discovering new molecules) is a time consuming and expensive process and is thus dominated by large global multinational. The pharmaceutical industry came into existence in 1901, The first Pharmaceutical company was “Bengal chemical and pharmaceutical Works Ltd. is public sector undertaking, established in Kolkata, west Bengal, by “Prafulla Chandra Ray”.[2] In the next few decades, the pharmaceutical industry moving through several phases, largely in accordance with government policies, is commencing with repackaging and preparation of formulation from important bulk drugs. According to study of India‟s pharmaceutical exports, it stood at US$17.27[1] billions in 2017-18, in 2018-19 this export are expected to cross US$19[1] billion. Some of recent development/ investment in the Indian pharmaceutical sector are as follows: 1. In August 2018, the market grew by 8.7% year on year with sells of Rs 11,342 corer. 2. During April- June 2018 pharmaceutical sector in India witnessed private equity and venture capital investment of US$396 million.

Keywords: .


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW MARCH ISSUE PUBLISHED

    MARCH 2019 Issue has been successfully launched on 1 March 2019

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT